Meaning-Centered Psychotherapy for Addressing Existential Distress of Patient/Caregiver Dyads Following Hematopoietic Stem Cell Transplantation: Feasibility and Acceptability

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMayo Clinic

About this trial

The purpose of this study is to learn whether Meaning-Centered Psychotherapy (MCP-Dyad) is practical, acceptable, and helpful to survivors and caregivers during recovery after stem cell transplant. MCP-Dyad is a meaning-focused support program. It is designed to help people stay connected to meaning, cope with difficult experiences, and communicate as a pair during recovery.

Eligibility criteria

Qualifiers

Eligible patients and their caregivers must be adults (≥18 years)

Patient must have undergone HSCT for a malignant blood cancer condition

Caregiver must be the main support person (e.g., signed caregiving contract) for the HSCT patient

Both the patient and their caregiver must be willing to participate in the study (dyads only)

Disqualifiers

Patients undergoing HSCT for nonmalignant conditions

Patients and caregivers with severe cognitive or psychiatric impairment that may affect informed consent/participation

Prisoners, pregnant women, and institutionalized persons

Patients with severe cognitive or psychiatric impairment that would affect informed consent or participation

Trial design

Treatments tested in this trial

  • Meaning-Centered Psychotherapy
  • Usual Care

Treatment groups

100 Participants
are divided into 2 treatment groups

Sponsors and collaborators